Slow-channel myasthenie syndrome caused by enhanced activation and agonist binding affinity due to mutation in the M2 domain of the ACHR α subunit

M. Milone, H. L. Wang, K. Ohno, T. Fukudome, Jerry N Pruitt, N. Bren, S. M. Sine, A. G. Engel

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Slow-channel myasthenie syndrome caused by enhanced activation and agonist binding affinity due to mutation in the M2 domain of the ACHR α subunit'. Together they form a unique fingerprint.

Medicine & Life Sciences